download-4.pngWe were very excited this Monday to announce a new partnership with APCER Life Sciences, a global provider of safety, medical, regulatory, and technology services to the pharmaceutical industry.  Working with the dedicated professionals at APCER will enable us to expand our reach into the safety and pharmacovigilance departments at pharmaceutical companies globally. 

As I wrote in my last blog post, PV departments are moving away from just case processing and basic signal detection and starting to embrace data, informatics, and multiple evidence sources.  Our model at Advera fits the bill quite well and our new partnership with APCER will help us serve those clients better and faster.

We’re excited to kick off 2017 with a new partnership!  You can read more about this news here and feel free to contact us with any questions.


Brian M. Overstreet, President, Advera Health Analytics, Inc.


Topics: Drug Safety, HEOR

Brian Overstreet

Written by Brian Overstreet